iSpecimen (ISPC) CEO On Biospecimens

<p>iSpecimen (ISPC) stock price is down about 7% so far today. The company is a source for human biospecimens for life science research. It supports supply chain management and bioprocurement processes for specimens. iSpecimen consolidates biospecimen buying in an online marketplace. CEO Chris Ianelli weighs in on the role of biospecimen availability in the fight against Covid-19.</p><p><br></p>